BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16696564)

  • 1. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry.
    Hah SS; Stivers KM; de Vere White RW; Henderson PT
    Chem Res Toxicol; 2006 May; 19(5):622-6. PubMed ID: 16696564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations.
    Hah SS; Sumbad RA; de Vere White RW; Turteltaub KW; Henderson PT
    Chem Res Toxicol; 2007 Dec; 20(12):1745-51. PubMed ID: 18001055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
    Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of carbonate in the cytotoxicity of carboplatin.
    Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
    Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and theoretical studies on the pharmacodynamics of cisplatin in jurkat cells.
    Tacka KA; Szalda D; Souid AK; Goodisman J; Dabrowiak JC
    Chem Res Toxicol; 2004 Nov; 17(11):1434-44. PubMed ID: 15540941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW; Goldenberg S; Pastan I; Gottesman MM
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L; Di Mario F; Botti P; Ragazzi E; Martelli M; Kelland L
    Biochem Pharmacol; 2007 Jun; 74(1):20-7. PubMed ID: 17466278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues.
    Aronov O; Horowitz AT; Gabizon A; Fuertes MA; PĂ©rez JM; Gibson D
    Bioconjug Chem; 2004; 15(4):814-23. PubMed ID: 15264869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.
    Bedford P; Fichtinger-Schepman AM; Shellard SA; Walker MC; Masters JR; Hill BT
    Cancer Res; 1988 Jun; 48(11):3019-24. PubMed ID: 3365691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity.
    McDonald ES; Randon KR; Knight A; Windebank AJ
    Neurobiol Dis; 2005 Mar; 18(2):305-13. PubMed ID: 15686959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R; Kalke R; Li XF
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the platinum analogues in bladder cancer cell lines.
    Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
    Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.
    Wang S; Zhang H; Malfatti M; de Vere White R; Lara PN; Turteltaub K; Henderson P; Pan CX
    Chem Res Toxicol; 2010 Nov; 23(11):1653-5. PubMed ID: 21028869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-induced carboplatin-DNA adduct levels in human ovarian tumours in relation to assessment of adduct measurement in mouse tissues.
    Jarvis IW; Meczes EL; Thomas HD; Edmondson RJ; Veal GJ; Boddy AV; Ottley CJ; Pearson DG; Tilby MJ
    Biochem Pharmacol; 2012 Jan; 83(1):69-77. PubMed ID: 22015635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
    Fichtinger-Schepman AM; van Dijk-Knijnenburg HC; van der Velde-Visser SD; Berends F; Baan RA
    Carcinogenesis; 1995 Oct; 16(10):2447-53. PubMed ID: 7586150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity.
    Calvert H; Judson I; van der Vijgh WJ
    Cancer Surv; 1993; 17():189-217. PubMed ID: 8137341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.